Project Grant 2521606
- This Project Grant award of $651,084, made by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports research to determine how microbes influence the response of their mosquito host to climate change, with a focus on the impacts on Hawaiian honeycreepers, an endangered bird species. The research aims to: Clarify the landscape-scale population dynamics of the mosquito vector Culex quinquefasciatus and its microbiome across an elevational gradient in Hawaii....
- The National Science Foundation awarded a $500,000 Project Grant to the University of Washington under the Biological Sciences federal grant program (CFDA 47.074) to investigate olfactory learning and neuromodulation in the Aedes aegypti mosquito from June 1, 2023 to May 31, 2026. The research aims to understand how odor learning modifies mosquitoes' biting behaviors through three objectives: testing whether mosquitoes only learn certain odors corresponding to antennal lobe glomeruli tuning;...
- The National Science Foundation awarded a $207,000 Project Grant to support research from August 1, 2021 to July 31, 2024 titled "Mosquito-Borne Disease Networks and Variation in Transmission Traits Across a Gradient of Anthropogenic Impact." The grant was awarded under the Biological Sciences program (CFDA 47.074) to further the program's goals of advancing the biological sciences and strengthening the national scientific enterprise through increasing scientific knowledge and...
- This Project Grant award from the National Science Foundation (CFDA 47.049 - Mathematical and Physical Sciences) will develop an early-warning system to forecast surges in disease-carrying mosquito populations in the United States. The $300,000 award, effective September 1, 2025 through August 31, 2028, will create modeling tools and ensembling approaches to generate 1- to 4-week ahead forecasts of the relative abundance of Aedes aegypti and Aedes albopictus mosquitoes. The forecasts will be...
- The Project Grant titled "Impact of Antimalarials on Parasite Selection Through the Mosquito Vector" is funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $192,364 award, which runs from August 2025 to July 2030, supports research at Yale University to investigate the effect of antimalarial drugs taken by humans on the development of malaria parasites within mosquitoes. The...
- This National Science Foundation (NSF) Directorate for Mathematical and Physical Sciences (CFDA 47.049) Project Grant of $246,620 awarded to The University of Texas at San Antonio (UTSA) will fund the development of novel mathematical models for Wolbachia-based strategies to control mosquito-borne diseases like dengue fever, malaria, chikungunya, and Zika. The multi-stage models will account for the complex transmission dynamics, spatial and temporal heterogeneity, and Wolbachia's biological...
- This Project Grant award of $132,050 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research on the impact of the mosquito gut microbiota on regulating egg formation and malaria infection. The University of Georgia Research Foundation, Inc. is conducting this research to understand how mosquito gut microbes and insulin signaling pathways interact to influence mosquito reproduction and...
- This two-year $138,000 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) will fund postdoctoral research characterizing the role of Wolbachia in an insect vector-virus pathosystem. The grant recipient will conduct research at Athens, Georgia from September 2021 through August 2023 to further the program's goals of strengthening the nation's biological sciences enterprise and increasing scientific knowledge of major problems. Funding will support the...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $695,801 to Baylor University to investigate the evolution and coevolution of the invasive Anopheles stephensi mosquito and the Plasmodium parasite in Africa. The key goals are to identify the genomic bases of adaptation in the invasive mosquito and its susceptibility to local African Plasmodium falciparum strains. This knowledge will be used...
- This Project Grant award of $699,814 from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 - Allergy and Infectious Diseases Research, aims to study molecular mechanisms of Plasmodium parasite invasion in Anopheles mosquito midguts to identify novel targets for transmission-blocking malaria vaccines. The key products and services to be delivered under this award include: Functional characterization of identified mosquito and parasite proteins that mediate...
This Project Grant award, totaling $650,970.00, was provided by the National Science Foundation's (NSF) Office of International Science and Engineering (CFDA 47.079) to Michigan State University from August 1, 2025 to July 31, 2028. The purpose of the grant is to explore how genetic, environmental, and microbiome factors impact the ability of Wolbachia bacteria to control Anopheles mosquitoes, a major vector for malaria transmission. The research aims to develop novel, environmentally sustainable control strategies to reduce the global burden of malaria. Key objectives include creating stable Wolbachia-infected Anopheles mosquito lines, identifying native Wolbachia strains, and understanding how mosquito genetics and the gut microbiome affect Wolbachia-based control methods. This work has the potential to generate biotechnology innovations that will benefit public health both domestically and internationally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $651.0k | 7/28/25 |